DISCOVER Publications

Bibliography

DISCOVER will provide unprecedented insights into the management of patients with type 2 diabetes mellitus globally and in each country involved. As soon as publications are available, they will be included here. Please check back regularly to keep up to date with the latest developments.

Articles

1. Ji L, Bonnet F, Charbonnel B, Gomes MB, Kosiborod M, Khunti K, Nicolucci A, Pocock S, Rathmann W, Shestakova MV, Shimomura I, Watada H, Fenici P, Hammar N, Hashigami K, Macaraeg G, Surmont F, Medina J. Towards an improved global understanding of treatment and outcomes in people with type 2 diabetes: Rationale and methods of the DISCOVER observational study program. J Diabetes Complications 2017;31(7):1188–96.

2. Khunti K, Gomes MB, Pocock S, Shestakova MV, Pintat S, Fenici P, Hammar N, Medina J. Therapeutic inertia in the treatment of hyperglycaemia in patients with type 2 diabetes: a systematic review. Diabetes Obes Metab. Published online 22 August 2017.

Available from: doi.org/10.1111/dom.13088

3. Khunti K, Godec TR, MedinaJ, Garcia-Alvarez L, Hiller J, Gomes MB, Cid-Ruzafa J, Charbonnel B, Fenici P, Hammar N, Hashigami K, Kosiborod M, Nicolucci A, Shestakova MV, Ji L, Pocock S. Patterns of glycaemic control in patients with type 2 diabetes mellitus initiating second-line therapy after metformin monotherapy: Retrospective data for 10 256 individuals from the United Kingdom and Germany. Diabetes Obes Metab. Published online 17 August 2017.

Available from: doi.org/10.1111/dom.13083

Abstracts

1. Ji L, Charbonnel B, Cook W, Fenici P, García-Sanchez R, Gomes MB, Hammar N, Hashigami K, Khunti K, Nicolucci A, Shestakova MV, Shimomura I, Surmont FA, Medina J. DISCOVER – a global study program to assess real world evidence on treatment and outcomes of patients with type 2 diabetes (T2D). Published at the 75th Scientific Sessions of the American Diabetes Association, 5–9 June 2015, Boston, MA, USA.

Available from: http://app.core-apps.com/tristar_ada15/abstract/160858d53930b598d64b10f393d55b14 (Accessed July 2016).

Oral presentations

1. Kosiborod M, Cid-Ruzafa J, Fenici P, Gomes MB, Hammar N, Nicolucci A, Pocock S, Rathmann W, Shestakova MV, Shimomura I, Tang F, Watada H, Khunti K. Global prevalence of type 2 diabetes complications in 14 178 patients initiating second-line therapy: the DISCOVER study. Presented at the 77th Scientific Sessions of the American Diabetes Association, 9-13 June 2017, San Diego, California, USA.

Posters

1. Charbonnel B, Gomes MB, Khunti K, Nicolucci A, Pocock S, Shestakova MV, Fenici P, García-Álvarez L, Hammar N, Hashigami K, Hiller J, Medina J, Surmont FA, Ji L. DISCOVERing treatment of type 2 diabetes in real world settings using electronic medical record databases. Presented at the European Association for the Study of Diabetes Annual Meeting, 14–18 September, 2015, Stockholm, Sweden.

Available from http://www.easdvirtualmeeting.org/resources/discovering-treatment-of-type-2-diabetes-in-real-world-settings-using-electronic-medical-record-databases--3 (Accessed July 2016).

2. Lindh A, Persson F, Sobocki P, Bodegård J, Lindarck N. Nordic longitudinal data from electronic records and full population national registers: unique opportunities for new insights in benefit of diabetes patients. Presented at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), 7–11 November 2015, Milan, Italy.

Available from: http://www.ispor.org/research_pdfs/51/pdffiles/PRM246.pdf (Accessed July 2016).

3. Pocock S, Charbonnel B, Gomes MB, Khunti K, Kosiborod M, Nicolucci A, Shestakova MV, Fenici P, Hammar N, Hashigami K, Hiller J, Lillie M, Macaraeg G, Medina J, Ji L. Suboptimal glycaemic control in patients with type 2 diabetes: retrospective data from 22 272 individuals. Presented at the 76th Scientific Sessions of the American Diabetes Association, 10–14 June 2016, New Orleans, Louisiana, USA.

Available by searching 1558-P from: https://ada.apprisor.org/epsWelcome.cfm?CFID=4977608&CFTOKEN=fad95491bb095ec3-4A5EB48C-0D0E-440D-33D894321FD81CE0 (Accessed July 2016).

4. Nicolucci A, Charbonnel B, Gomes MB, Khunti K, Kosiborod M, Pocock S, Shestakova MV, Fenici P, Hammar N, Hashigami K, Hiller J, Lillie M, Macaraeg G, Medina J, Ji L. Suboptimal glycaemic control in patients with type 2 diabetes: retrospective data from 22,272 individuals. Presented at the European Association for the Study of Diabetes Annual Meeting, 12-16 September, 2016, Munich, Germany.

Available from http://www.easdvirtualmeeting.org/resources/suboptimal-glycaemic-control-in-patients-with-type-2-diabetes-retrospective-data-from-22-272-individuals-c0e1984e-28d3-40ee-ad7d-6e60f3ca9e9a (Accessed October 2016).

5. Harmand S, Maillard C, Thomas-Delecourt F. Étude DISCOVER France. Poster presented at Colloque des données de santé en vie réelle (local French congress) / Real Life Health Data Symposium 13th June 2017, Paris, France.

6. Nicolucci A, Arya N, Charbonnel B, Cid-Ruzafa J, Fenici P, Gomes MB, Hammar N, Khunti K, Kosiborod M, Shestakova MV, Shimomura I, Tang F, Watada H, Pocock S. Treatment Patterns and Associated Factors in 13,379 Patients with Type 2 Diabetes Initiating a Second-Line Therapy: The DISCOVER Study. Presented at the 77th Scientific Sessions of the American Diabetes Association, 9-13 June 2017, San Diego, California, USA.

Available by searching 1675-P from: https://ada.apprisor.org/epsWelcome.cfm?CFID=5729155&CFTOKEN=25031eff7b6ddbbf-58969954-F81C-E23D-91882B392B9FD2D0 (Accessed June 2017).

7. Khunti K, Arya N, Cid-Ruzafa J, Fenici P, Gomes MB, Hammar N, Ji L, Kosiborod M, Pocock S, Shestakova MV, Shimomura I, Tang F, Watada H, Nicolucci A. Glycaemic Control in 14,005 Patients with Type 2 Diabetes Initiating Second-Line Therapy in 36 Countries: The DISCOVER Study. Presented at the 77th Scientific Sessions of the American Diabetes Association, 9-13 June 2017, San Diego, California, USA.

Available by searching 1675-P from: https://ada.apprisor.org/epsWelcome.cfm?CFID=5729155&CFTOKEN=25031eff7b6ddbbf-58969954-F81C-E23D-91882B392B9FD2D0 (Accessed June 2017).

8. Shestakova MV, Cid-Ruzafa J, Fenici P, Gomes MB, Hammar N, Kosiborod M, Nicolucci A, Pocock S, Rathmann W, Shimomura I,Tang F, Watada H, Khunti K. Global prevalence of type 2 diabetes complications in 14 178 patients initiating second-line therapy: the DISCOVER study. Encore from ADA 2017; presented at the European Association for the Study of Diabetes Annual Meeting, 11–15 September, 2017, Lisbon, Portugal.

Available by searching 1126 on https://www.easd.org/virtualmeeting/home.html (Accessed September 2017).

9. Nicolucci A, Arya N, Charbonnel B, Cid-Ruzafa J, Fenici P, Gomes MB, Hammar N, Khunti K, Kosiborod M, Shestakova MV, Shimomura I, Tang F, Watada H, Pocock S. Treatment patterns and associated factors in 13 128 patients with type 2 diabetes initiating a second-line therapy: the DISCOVER study. Encore from ADA 2017; presented at the European Association for the Study of Diabetes Annual Meeting, 11–15 September, 2017, Lisbon, Portugal.

Available by searching 662 on https://www.easd.org/virtualmeeting/home.html (Accessed September 2017).

10. Ji L, Nicolucci A, Arya N, Cid-Ruzafa J, Fenici P, Gomes MB, Hammar N, Kosiborod M, Pocock S, Shestakova MV, Watada H, Shimomura I, Tang F, Khunti K. Glycaemic control in 13 791 patients with type 2 diabetes initiating second-line therapy in 36 countries: the DISCOVER study. Encore from ADA 2017; presented at the European Association for the Study of Diabetes Annual Meeting, 11–15 September, 2017, Lisbon, Portugal.

Available by searching 302 on https://www.easd.org/virtualmeeting/home.html (Accessed September 2017).

11. Khunti K, Cid-Ruzafa J, Fenici P, Gomes MB, Hammar N, Kosiborod M, Nicolucci A, Pocock S, Rathmann W, Shestakova MV, Watada H, Shimomura I, Tang F, Ji L. Factors associated with the discontinuation of metformin therapy: results from 11 452 patients in the global DISCOVER study. Presented at the European Association for the Study of Diabetes Annual Meeting, 11–15 September, 2017, Lisbon, Portugal.

Available by searching 906 on https://www.easd.org/virtualmeeting/home.html (Accessed September 2017).

12. Gomes MB, Charbonnel B, Cid-Ruzafa J, Fenici P, Hammar N, Khunti K, Kosiborod M, Nicolucci A, Pocock S, Shestakova MV, Watada H, Shimomura I, Tang F, Ji L. Glycaemic, lipid and blood pressure control according to guidelines in patients initiating second-line glucose-lowering therapy: results from the global DISCOVER study. Presented at the European Association for the Study of Diabetes Annual Meeting, 11–15 September, 2017, Lisbon, Portugal.

Available by searching 301 on https://www.easd.org/virtualmeeting/home.html (Accessed September 2017).

Abstracts

1. Ji L, Charbonnel B, Cook W, Fenici P, García-Sanchez R, Gomes MB, Hammar N, Hashigami K, Khunti K, Nicolucci A, Shestakova MV, Shimomura I, Surmont FA, Medina J. DISCOVER – a global study program to assess real world evidence on treatment and outcomes of patients with type 2 diabetes (T2D). Published at the 75th Scientific Sessions of the American Diabetes Association, 5–9 June 2015, Boston, MA, USA.

Available from: http://app.core-apps.com/tristar_ada15/abstract/160858d53930b598d64b10f393d55b14 (Accessed July 2016).

Posters

1. Charbonnel B, Gomes MB, Khunti K, Nicolucci A, Pocock S, Shestakova MV, Fenici P, García-Álvarez L, Hammar N, Hashigami K, Hiller J, Medina J, Surmont FA, Ji L. DISCOVERing treatment of type 2 diabetes in real world settings using electronic medical record databases. Presented at the European Association for the Study of Diabetes Annual Meeting, 14–18 September, 2015, Stockholm, Sweden.

Available from http://www.easdvirtualmeeting.org/resources/discovering-treatment-of-type-2-diabetes-in-real-world-settings-using-electronic-medical-record-databases--3 (Accessed July 2016).

2. Lindh A, Persson F, Sobocki P, Bodegård J, Lindarck N. Nordic longitudinal data from electronic records and full population national registers: unique opportunities for new insights in benefit of diabetes patients. Presented at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), 7–11 November 2015, Milan, Italy.

Available from: http://www.ispor.org/research_pdfs/51/pdffiles/PRM246.pdf (Accessed July 2016).

3. Pocock S, Charbonnel B, Gomes MB, Khunti K, Kosiborod M, Nicolucci A, Shestakova MV, Fenici P, Hammar N, Hashigami K, Hiller J, Lillie M, Macaraeg G, Medina J, Ji L. Suboptimal glycaemic control in patients with type 2 diabetes: retrospective data from 22 272 individuals. Presented at the 76th Scientific Sessions of the American Diabetes Association, 10–14 June 2016, New Orleans, Louisiana, USA.

Available by searching 1558-P from: https://ada.apprisor.org/epsWelcome.cfm?CFID=4977608&CFTOKEN=fad95491bb095ec3-4A5EB48C-0D0E-440D-33D894321FD81CE0 (Accessed July 2016).

4. Nicolucci A, Charbonnel B, Gomes MB, Khunti K, Kosiborod M, Pocock S, Shestakova MV, Fenici P, Hammar N, Hashigami K, Hiller J, Lillie M, Macaraeg G, Medina J, Ji L. Suboptimal glycaemic control in patients with type 2 diabetes: retrospective data from 22,272 individuals. Presented at the European Association for the Study of Diabetes Annual Meeting, 12-16 September, 2016, Munich, Germany.

Available from http://www.easdvirtualmeeting.org/resources/suboptimal-glycaemic-control-in-patients-with-type-2-diabetes-retrospective-data-from-22-272-individuals-c0e1984e-28d3-40ee-ad7d-6e60f3ca9e9a (Accessed October 2016).

5. Harmand S, Maillard C, Thomas-Delecourt F. Étude DISCOVER France. Poster presented at Colloque des données de santé en vie réelle (local French congress) / Real Life Health Data Symposium 13th June 2017, Paris, France.

6. Nicolucci A, Arya N, Charbonnel B, Cid-Ruzafa J, Fenici P, Gomes MB, Hammar N, Khunti K, Kosiborod M, Shestakova MV, Shimomura I, Tang F, Watada H, Pocock S. Treatment Patterns and Associated Factors in 13,379 Patients with Type 2 Diabetes Initiating a Second-Line Therapy: The DISCOVER Study. Presented at the 77th Scientific Sessions of the American Diabetes Association, 9-13 June 2017, San Diego, California, USA.

Available by searching 1675-P from: https://ada.apprisor.org/epsWelcome.cfm?CFID=5729155&CFTOKEN=25031eff7b6ddbbf-58969954-F81C-E23D-91882B392B9FD2D0 (Accessed June 2017).

7. Khunti K, Arya N, Cid-Ruzafa J, Fenici P, Gomes MB, Hammar N, Ji L, Kosiborod M, Pocock S, Shestakova MV, Shimomura I, Tang F, Watada H, Nicolucci A. Glycaemic Control in 14,005 Patients with Type 2 Diabetes Initiating Second-Line Therapy in 36 Countries: The DISCOVER Study. Presented at the 77th Scientific Sessions of the American Diabetes Association, 9-13 June 2017, San Diego, California, USA.

Available by searching 1675-P from: https://ada.apprisor.org/epsWelcome.cfm?CFID=5729155&CFTOKEN=25031eff7b6ddbbf-58969954-F81C-E23D-91882B392B9FD2D0 (Accessed June 2017).

8. Shestakova MV, Cid-Ruzafa J, Fenici P, Gomes MB, Hammar N, Kosiborod M, Nicolucci A, Pocock S, Rathmann W, Shimomura I,Tang F, Watada H, Khunti K. Global prevalence of type 2 diabetes complications in 14 178 patients initiating second-line therapy: the DISCOVER study. Encore from ADA 2017; presented at the European Association for the Study of Diabetes Annual Meeting, 11–15 September, 2017, Lisbon, Portugal.

Available by searching 1126 on https://www.easd.org/virtualmeeting/home.html (Accessed September 2017).

9. Nicolucci A, Arya N, Charbonnel B, Cid-Ruzafa J, Fenici P, Gomes MB, Hammar N, Khunti K, Kosiborod M, Shestakova MV, Shimomura I, Tang F, Watada H, Pocock S. Treatment patterns and associated factors in 13 128 patients with type 2 diabetes initiating a second-line therapy: the DISCOVER study. Encore from ADA 2017; presented at the European Association for the Study of Diabetes Annual Meeting, 11–15 September, 2017, Lisbon, Portugal.

Available by searching 662 on https://www.easd.org/virtualmeeting/home.html (Accessed September 2017).

10. Ji L, Nicolucci A, Arya N, Cid-Ruzafa J, Fenici P, Gomes MB, Hammar N, Kosiborod M, Pocock S, Shestakova MV, Watada H, Shimomura I, Tang F, Khunti K. Glycaemic control in 13 791 patients with type 2 diabetes initiating second-line therapy in 36 countries: the DISCOVER study. Encore from ADA 2017; presented at the European Association for the Study of Diabetes Annual Meeting, 11–15 September, 2017, Lisbon, Portugal.

Available by searching 302 on https://www.easd.org/virtualmeeting/home.html (Accessed September 2017).

11. Khunti K, Cid-Ruzafa J, Fenici P, Gomes MB, Hammar N, Kosiborod M, Nicolucci A, Pocock S, Rathmann W, Shestakova MV, Watada H, Shimomura I, Tang F, Ji L. Factors associated with the discontinuation of metformin therapy: results from 11 452 patients in the global DISCOVER study. Presented at the European Association for the Study of Diabetes Annual Meeting, 11–15 September, 2017, Lisbon, Portugal.

Available by searching 906 on https://www.easd.org/virtualmeeting/home.html (Accessed September 2017).

12. Gomes MB, Charbonnel B, Cid-Ruzafa J, Fenici P, Hammar N, Khunti K, Kosiborod M, Nicolucci A, Pocock S, Shestakova MV, Watada H, Shimomura I, Tang F, Ji L. Glycaemic, lipid and blood pressure control according to guidelines in patients initiating second-line glucose-lowering therapy: results from the global DISCOVER study. Presented at the European Association for the Study of Diabetes Annual Meeting, 11–15 September, 2017, Lisbon, Portugal.

Available by searching 301 on https://www.easd.org/virtualmeeting/home.html (Accessed September 2017).